Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

$RXRX stock is down 3% today. Here's what we see in our data.

None

$RXRX stock has now fallen 3% today, according to our price data from Polygon. There has been approximately $8,483,044 of trading volume.

It has been the 62nd most-searched ticker on Quiver Quantitative over the last day, out of 12,288 total tickers searched.

Here is what we see in our data on $RXRX (you can track the company live on Quiver's $RXRX stock page):

$RXRX Insider Trading Activity

RXRX Insider Trades

$RXRX insiders have traded $RXRX stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.

Here’s a breakdown of recent trading of $RXRX stock by insiders over the last 6 months:

  • BLAKE BORGESON has made 0 purchases and 6 sales selling 330,000 shares for an estimated $1,153,200.
  • CHRISTOPHER GIBSON has made 0 purchases and 5 sales selling 200,000 shares for an estimated $666,400.
  • NAJAT KHAN (CEO and President) has made 0 purchases and 2 sales selling 51,886 shares for an estimated $179,118.
  • NAMANDJE BUMPUS has made 0 purchases and 2 sales selling 8,349 shares for an estimated $28,128.
  • BEN R TAYLOR (Chief Financial Officer) sold 7,956 shares for an estimated $26,970

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$RXRX Hedge Fund Activity

We have seen 177 institutional investors add shares of $RXRX stock to their portfolio, and 176 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$RXRX Price Targets

Multiple analysts have issued price targets for $RXRX recently. We have seen 3 analysts offer price targets for $RXRX in the last 6 months, with a median target of $8.0.

Here are some recent targets:

  • Vikram Purohit from Morgan Stanley set a target price of $5.5 on 05/14/2026
  • Gil Blum from Needham set a target price of $8.0 on 05/07/2026
  • Priyanka Grover from JP Morgan set a target price of $10.0 on 04/30/2026

You can track data on $RXRX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles